Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China

Maintenance treatment is a pivotal part in the whole process management of multiple myeloma (MM), which further deepens response and improves survival. However, evidence of maintenance in non-transplant MM patients is inadequate in real-world practice. Here, we retrospectively analyzed the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Zhe, Tian, Ying, Shi, Lei, Zou, Dongmei, Feng, Ru, Tian, Wei-wei, Yu, Hong, Dong, Fei, Liao, Aijun, Ma, Yanping, Liu, Qinhua, Liu, Shuangjiao, Jing, Hongmei, Fu, Rong, Ma, Liang-ming, Liu, Hui, Sun, Wanling, Bao, Li, Wu, Yin, Chen, Wenming, Zhuang, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157094/
https://www.ncbi.nlm.nih.gov/pubmed/37152063
http://dx.doi.org/10.3389/fonc.2023.1028571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157094/
https://www.ncbi.nlm.nih.gov/pubmed/37152063
http://dx.doi.org/10.3389/fonc.2023.1028571

Ejemplares similares